Graf, Selianne Félice MaraSelianne Félice MaraGrafEgle, ManuelManuelEgleSanz-Garcia, Maria NievesMaria NievesSanz-GarciaSegiser, AdrianAdrianSegiserClavier, Alexia Aurélia Danielle MaryvonneAlexia Aurélia Danielle MaryvonneClavierArnold, Maria RegulaMaria RegulaArnoldGsponer, DidierDidierGsponerBartkevics, MarisMarisBartkevicsKadner, AlexanderAlexanderKadnerSiepe, MatthiasMatthiasSiepe0000-0001-8649-1098Vermathen, PeterPeterVermathenHenning Longnus, SarahSarahHenning Longnus2024-10-212024-10-212025-01https://boris-portal.unibe.ch/handle/20.500.12422/47859Background Heart transplantation with donation after circulatory death and ex-situ heart perfusion offers excellent outcomes and increased transplantation rates. However, improved graft evaluation techniques are required to ensure effective utilization of grafts. Therefore, we investigated circulating factors, both in-situ and ex-situ, as potential biomarkers for cardiac graft quality. Methods Circulatory death was simulated in anesthetized male pigs with warm ischemic durations of 0, 10, 20, or 30 minutes. Hearts were explanted and underwent ex-situ perfusion for 3 hours in an unloaded mode, followed by left ventricular loading for 1 hour, to evaluate cardiac recovery (outcomes). Multiple donor blood and ex-situ perfusate samples were used for biomarker evaluation with either standard biochemical techniques or nuclear magnetic resonance spectroscopy. Results Circulating adrenaline, both in the donor and at 10 minutes ex-situ heart perfusion, negatively correlated with cardiac recovery (p < 0.05 for all). We identified several new potential biomarkers for cardiac graft quality that can be measured rapidly and simultaneously with nuclear magnetic resonance spectroscopy. At multiple timepoints during unloaded ex-situ heart perfusion, perfusate levels of acetone, betaine, creatine, creatinine, fumarate, hypoxanthine, lactate, pyruvate and succinate (p < 0.05 for all) significantly correlated with outcomes; the optimal timepoint being 60 minutes. Conclusions In heart donation after circulatory death, circulating adrenaline levels are valuable for cardiac graft evaluation. Nuclear magnetic resonance spectroscopy is of particular interest, as it measures multiple metabolites in a short timeframe. Improved biomarkers may allow more precision and therefore better support clinical decisions about transplantation suitability.enDCD heart transplantationNMR spectroscopybiomarkerscardiac graft evaluationex-situ heart perfusion/ex-vivo heart perfusion/normothermic machine perfusion600 - Technology::610 - Medicine & healtharticle10.48620/363593925111410.1016/j.healun.2024.08.016